Micro Interventional Devices, a Newtown, Pennsylvania firm, obtained European CE Mark approval for its Permaseal device that allows surgeons to create a window into the left ventricle for delivery of tools, and to then close it once the procedure is complete. This obviates the necessity of suturing the myocardium, thanks to the firm’s PolyCor anchoring technology.
The device sticks eight anchors into the myocardium that are connected by a suture that remains on the surface of the heart. The anchors create an opening into the left ventricle for tools to move through. Once complete, the suture is pulled on and the anchors come together to close the working window.
Check out the device’s product page to view a video of the delivery and deployment of the Permaseal device.
From the announcement:
Permaseal was validated in the STASIS Clinical Study (Secure Transapical Access and Closure Study) conducted at five European Sites. Results indicated that Permaseal shortened operating time and hospital stay, reduced adverse events including the need for transfusion and reduced 12-month mortality and stroke rates to 0%*. The technology provides a direct, safe and simple, access and closure site for emerging complex structural heart disease procedures including TAVR, TMVR, PFO, and other minimally invasive cardiac procedures.
Product page: Permaseal…